Sunday, November 17, 2019 7:19:55 PM
As the only publicly traded company in America producing and selling a full lineup of Pure CBD Oil products, as well as growing and processing hemp for CBD Isolate, CANB is best positioned to deliver a windfall to its investors in 2019-2020 due to the FDA permitting Pure CBD in dietary supplements to sell nationally
Mile High Labs and Medterra are two of the biggest CBD Isolate and Pure CBD product companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to CBD Isolate and Pure CBD products besides CANB?
Being the only CBD Oil stock in America utilizing the formulation of CBD most likely to be federally legalized by the FDA is certainly the most obvious advantage that CANB has over the rest of the sector:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152129318
But there are several other advantages that CANB possesses, and the following favorable factors are acting synergistically with CANB’s Pure CBD formulation to give it the greatest % gain potential from current prices in the CBD Oil sector:
1. Best financing in the sector
Private Placements at zero discount to market in August (restricted shares)
$4,000,000 raised at $.029
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152131404
2. Most rapid annual revenue growth in the sector
500% revenue growth year-over-year
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151962562
3. Only processor of raw hemp into CBD Isolate (as opposed to Full Spectrum CBD)
That is a unique advantage because CBD Isolate Processing is a huge market, there’s a tremendous lack of processors, and as has already been stated, Pure CBD is likely to be the only formulation to receive FDA approval for national sales
CANB is partnering with Mile High Labs for processing hemp
https://www.milehighlabs.com/
4. Complete vertical integration from seed to sale
CANB is also a grower of hemp as well, so they have achieved complete vertical integration and full control over the entire supply chain from seed to sale, thereby maximizing profit margins
CANB is partnering with Shi Farms for growing hemp
https://www.shifarms.com/
5. The depth and expertise of the corporate and medical advisory boards
8 MDs, 4 attorneys, 1 orthopedic surgeon and a Senator
https://canbiola.com/management-team/
6. Medical Sales
CANB sells to both the retail and medical markets, but they specialize in the sales of CBD Oil products to the medical & healthcare community, which is a far less crowded market
7. No convertible debt
Very rare on the OTC, as this is typically how these companies raise money
8. Potential to uplist to Nasdaq
Canbiola, Inc. (the “Company”) submitted an application to be listed on The Nasdaq Capital Market® on June 4, 2019. The Company intends to diligently pursue its application in order to have its securities listed on the Nasdaq Stock Market.
With a fully independent board of directors and the shareholder equity criteria now met, CANB now has the potential to uplist to the Nasdaq in 2020:
https://www.otcmarkets.com/filing/conv_pdf?id=13484913&guid=yRKSUW-VfXVyW3h
Sleek
SLEEKSCAPE’S GRAND SALAMI FOR 2020 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE’S-2020-HEMP-CBD-&-MARIJUANA-MANIA-GRAND-SALAMI-PART-II-31243/
Recent CANB News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:17:32 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 06:32:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:58:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 05:29:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 09:08:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:54:44 PM
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million • InvestorsHub NewsWire • 03/11/2024 12:34:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:02:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:52:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 06:08:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:18:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 02:44:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 06:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:57:21 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM